title: Characterization of metabolites of tanshinone IIA in rats by liquid chromatography/tandem mass spectrometry.
abstract: The metabolism of tanshinone IIA was studied in rats after a single-dose intravenous administration. In the present study, 12 metabolites of tanshinone IIA were identified in rat bile, urine and feces with two LC gradients using LC-MS/MS. Seven phase I metabolites and five phase II metabolites of tanshinone IIA were characterized and their molecular structures proposed on the basis of the characteristics of their precursor ions, product ions and chromatographic retention time. The seven phase I metabolites were formed, through two main metabolic routes, which were hydroxylation and dehydrogenation metabolism. M1, M4, M5 and M6 were supposedly tanshinone IIB, hydroxytanshinone IIA, przewaquinone A and dehydrotanshinone IIA, respectively, by comparing their HPLC retention times and mass spectral patterns with those of the standard compounds. The five phase II metabolites identified in this research were all glucuronide conjugates, all of which showed a neutral loss of 176 Da. M9 and M12 were more abundant than other identified metabolites in the bile, which was the main excretion path of tanshinone IIA and the metabolites. M12 was the main metabolite of tanshinone IIA. M9 and M12 were proposed to be the glucuronide conjugates of two different semiquinones and these semiquinones were the hydrogenation products of dehydrotanshinone IIA and tanshinone IIA, respectively. This hydrogenized reaction may be catalyzed by the NAD(P)H: quinone acceptor oxidoreductase (NQO). The biotransformation pathways of tanshinone IIA were proposed on the basis of this research.
authors.affiliation: Key Lab of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing 210038, China.
authors.forename: Peng
authors.initials: P
authors.lastname: Li
authors.forename: Guang-Ji
authors.initials: GJ
authors.lastname: Wang
authors.forename: Jing
authors.initials: J
authors.lastname: Li
authors.forename: Hai-Ping
authors.initials: HP
authors.lastname: Hao
authors.forename: Chao-Nan
authors.initials: CN
authors.lastname: Zheng
mesh_terms: D045784:Abietanes; D000818:Animals; D000890:Anti-Infective Agents / Q000737:chemistry / Q000493:pharmacokinetics* / Q000652:urine*; D001646:Bile / Q000378:metabolism; D002853:Chromatography, Liquid; D004365:Drugs, Chinese Herbal / Q000737:chemistry / Q000493:pharmacokinetics; D005243:Feces / Q000737:chemistry; D020719:Glucuronides / Q000652:urine; D006900:Hydroxylation; D007275:Injections, Intravenous; D010616:Phenanthrenes / Q000737:chemistry / Q000493:pharmacokinetics* / Q000652:urine*; D051381:Rats; D017207:Rats, Sprague-Dawley; D021241:Spectrometry, Mass, Electrospray Ionization
chemical_list: D045784:Abietanes; D000890:Anti-Infective Agents; D004365:Drugs, Chinese Herbal; D020719:Glucuronides; D010616:Phenanthrenes; C021751:tanshinone